FAQs

The Gene Therapy Analytical Development Europe Summit is Europe’s leading meeting dedicated to analytical development, potency assurance, QC strategy, and regulatory readiness for gene therapies.

The summit brings together analytical scientists, QC leaders, CMC experts, and regulators who are defining how potency, quality, safety, and consistency are measured across viral and non-viral gene therapy modalities.

Taking place in London, this specialist forum provides a highly technical, peer-level environment to address the analytical challenges that directly impact clinical progression and late-stage success.

The summit is designed for professionals responsible for analytical strategy, assay performance, and regulatory alignment across gene therapy programs.

Attendees typically include:

• Senior Analytical Development Scientists & Technical Leads
• QC & GMP Release Scientists
• Potency Assay Developers & Bioassay Experts
• CMC, MSAT & Tech Transfer Professionals
• Regulatory Affairs & CMC Strategy Leads
• Senior Viral Vector & Non-Viral Platform Scientists

This is a must-attend meeting for teams translating complex analytical data into confident development and regulatory decisions.

The 2026 agenda addresses the most pressing analytical challenges facing gene therapy developers, including:

• Potency assay design, variability reduction, and assurance strategies
• Phase-appropriate qualification versus validation
• Designing assays that survive tech transfer, scale-up, and PPQ
• Impurity profiling and safety considerations
• Universal reference materials, standardisation efforts, and regulatory alignment

Find out more in the full event guide.

Unlike broader gene therapy, manufacturing, or clinical meetings, this summit is exclusively focused on analytics.

Rather than covering vector design or clinical results at a high level, the program dives into:

• How assays are built and why they fail
• How results are interpreted
• What regulators expect
• How analytical decisions affect timelines and risk

This depth enables more technical discussions, relevant networking, and greater practical value for analytical and QC teams compared with general gene therapy or bioprocessing conferences.

Group discounts of up to 20% off are available when you attend with three or more colleagues.

Explore the registration options here.

For enquiries regarding registration, speaking opportunities, or press, please contact:
info@hansonwade.com

For sponsorship and partnership enquiries, please contact:
sponsor@hansonwade.com